38.39 USD
+0.03 (+0.08%)
Overall KEQU gets a fundamental rating of 4 out of 10. We evaluated KEQU against 187 industry peers in the Health Care Equipment & Supplies industry. KEQU has only an average score on both its financial health and profitability. KEQU has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year KEQU was profitable.
In the past year KEQU had a positive cash flow from operations.
In multiple years KEQU reported negative net income over the last 5 years.
In multiple years KEQU reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of KEQU (6.36%) is better than 85.56% of its industry peers.
KEQU's Return On Equity of 18.34% is amongst the best of the industry. KEQU outperforms 93.58% of its industry peers.
KEQU has a better Return On Invested Capital (10.92%) than 90.91% of its industry peers.
KEQU had an Average Return On Invested Capital over the past 3 years of 9.90%. This is in line with the industry average of 8.82%.
The last Return On Invested Capital (10.92%) for KEQU is above the 3 year average (9.90%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROIC | 10.92% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 4.68%, KEQU is doing good in the industry, outperforming 75.94% of the companies in the same industry.
KEQU has a Operating Margin of 7.60%. This is in the better half of the industry: KEQU outperforms 74.33% of its industry peers.
With a Gross Margin value of 29.37%, KEQU is not doing good in the industry: 77.01% of the companies in the same industry are doing better.
KEQU's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
2. Health
2.1 Basic Checks
KEQU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
KEQU has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, KEQU has more shares outstanding
The debt/assets ratio for KEQU is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.09 indicates that KEQU is not in any danger for bankruptcy at the moment.
KEQU's Altman-Z score of 3.09 is fine compared to the rest of the industry. KEQU outperforms 72.19% of its industry peers.
The Debt to FCF ratio of KEQU is 3.45, which is a good value as it means it would take KEQU, 3.45 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 3.45, KEQU belongs to the best of the industry, outperforming 82.89% of the companies in the same industry.
KEQU has a Debt/Equity ratio of 0.91. This is a neutral value indicating KEQU is somewhat dependend on debt financing.
KEQU has a Debt to Equity ratio of 0.91. This is in the lower half of the industry: KEQU underperforms 73.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Altman-Z | 3.09 |
ROIC/WACC1.4
WACC7.77%
2.3 Liquidity
KEQU has a Current Ratio of 2.32. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
KEQU has a Current ratio (2.32) which is in line with its industry peers.
A Quick Ratio of 1.63 indicates that KEQU should not have too much problems paying its short term obligations.
KEQU's Quick ratio of 1.63 is in line compared to the rest of the industry. KEQU outperforms 43.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 |
3. Growth
3.1 Past
KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.96%.
The earnings per share for KEQU have been decreasing by -18.78% on average. This is quite bad
The Revenue has decreased by -7.27% in the past year.
The Revenue has been growing slightly by 5.68% on average over the past years.
EPS 1Y (TTM)-71.96%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%N/A
Revenue 1Y (TTM)-7.27%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%46.76%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
KEQU is valuated cheaply with a Price/Earnings ratio of 7.60.
96.79% of the companies in the same industry are more expensive than KEQU, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.26, KEQU is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.6 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KEQU is valued cheaply inside the industry as 96.79% of the companies are valued more expensively.
98.40% of the companies in the same industry are more expensive than KEQU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.89 | ||
| EV/EBITDA | 6.07 |
4.3 Compensation for Growth
KEQU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
KEQU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:KEQU (12/19/2025, 11:12:28 AM)
38.39
+0.03 (+0.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners41.14%
Inst Owner Change1.56%
Ins Owners15.96%
Ins Owner Change0.44%
Market Cap110.18M
Revenue(TTM)146.60M
Net Income(TTM)12.30M
Analysts82.86
Price TargetN/A
Short Float %1%
Short Ratio1.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.6 | ||
| Fwd PE | N/A | ||
| P/S | 0.42 | ||
| P/FCF | 5.89 | ||
| P/OCF | 5.16 | ||
| P/B | 1.64 | ||
| P/tB | 2.97 | ||
| EV/EBITDA | 6.07 |
EPS(TTM)5.05
EY13.15%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.52
FCFY16.98%
OCF(TTM)7.45
OCFY19.39%
SpS91.7
BVpS23.37
TBVpS12.94
PEG (NY)N/A
PEG (5Y)N/A
Graham Number51.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROCE | 13.98% | ||
| ROIC | 10.92% | ||
| ROICexc | 12.63% | ||
| ROICexgc | 16.65% | ||
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% | ||
| FCFM | 7.11% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Debt/EBITDA | 2.38 | ||
| Cap/Depr | 48.41% | ||
| Cap/Sales | 1.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.84% | ||
| Profit Quality | 152.04% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 | ||
| Altman-Z | 3.09 |
F-Score4
WACC7.77%
ROIC/WACC1.4
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.96%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.27%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%46.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y496.38%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y2996.81%
OCF growth 3YN/A
OCF growth 5Y28.86%
KEWAUNEE SCIENTIFIC CP / KEQU FAQ
What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?
ChartMill assigns a fundamental rating of 4 / 10 to KEQU.
Can you provide the valuation status for KEWAUNEE SCIENTIFIC CP?
ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.
How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?
KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.
Can you provide the dividend sustainability for KEQU stock?
The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.